Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2003 08:00 ET | Source: BioCurex, Inc.

BioCurex Granted U.S. Patent for Cancer Diagnostic Products and FDA Clearance with a Market Potential Worth $2 Billion Dollars

RANCHO SANTA MARGARITA, Calif., March 11, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces that the U.S. Patent office has granted patent Nr. US6,514,685 B1 entitled "DETECTION OF CANCER...
February 27, 2003 11:26 ET | Source: BioCurex, Inc.

CEOcast Features BioCurex's Chairman

RANCHO SANTA MARGARITA, Calif., Feb. 27, 2003 (PRIMEZONE) - BioCurex, Inc. (OTCBB:BOCX) announced that an interview featuring Dr. Gerald Wittenberg, the company's Chairman, is currently available on...
January 23, 2003 09:00 ET | Source: BioCurex, Inc.

BioCurex in Discussions with Several Investment Groups

RANCHO SANTA MARGARITA, Calif., Jan. 23, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announced today that it is considering several proposals for funding of its research and operations and...
January 22, 2003 11:34 ET | Source: BioCurex, Inc.

FDA Clears BioCurex Histo-RECAF Kit for Commercialization as a Class I Device

RANCHO SANTA MARGARITA, Calif., Jan. 22, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces that its first product, Histo-RECAF(TM) has been classified by the FDA as a Class I device under...
January 15, 2003 09:00 ET | Source: BioCurex, Inc.

BioCurex Inc. Announces Company's Consideration of 'Certificate Only' Trading as Part of an Overall Re-Structure Initiative

RANCHO SANTA MARGARITA, Calif., Jan. 15, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announced today that it is considering a strategy which includes the possible adoption of "custody only" or...
January 09, 2003 14:37 ET | Source: BioCurex, Inc.

BioCurex and RJV Networks Create a Non-Toxic Therapeutic Antibody Cancer Treatment That May Arrest Development and Replication of Cancerous Cells

RANCHO SANTA MARGARITA, Calif., Jan. 9, 2003 (PRIMEZONE) -- BioCurex, Inc. (OTCBB:BOCX) announces further developments relating to its licensing agreement with BioKinetix, a company being acquired by...
December 18, 2002 07:00 ET | Source: BioCurex, Inc.

BioCurex Announces a Successful Presentation at the Annual Meeting of the International Society of Oncodevelopmental Biology and Medicine

RANCHO SANTA MARGARITA, Calif., Dec. 18, 2002 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) is pleased to announce the successful presentation of 6 communications related to its RECAF Technology at the...
December 16, 2002 07:00 ET | Source: BioCurex, Inc.

BioCurex Inc. Announces that it Has Completed a Licensing Agreement with BioKinetix

RANCHO SANTA MARGARITA, Calif., Dec. 16, 2002 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) is pleased to announce that it has completed a licensing agreement with BioKinetix to use BioCurex's RECAF...
September 09, 2002 05:00 ET | Source: BioCurex, Inc.

BioCurex Signs Up Major Distribution Partner for Canada

RANCHO SANTA MARGARITA, Calif., Sept. 9, 2002 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announced a second major distribution deal for its novel Histo-RECAF(tm) and Cryo-RECAF(tm) cancer diagnostic...
August 14, 2002 05:00 ET | Source: BioCurex, Inc.

BioCurex Teams Up with Aperio Technologies to Advance Cancer Detection

RANCHO SANTA MARGARITA, Calif., Aug. 14, 2002 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announced a collaboration with Aperio Technologies, Inc. (Vista, California) to automate the detection of the...